Skip to search formSkip to main contentSkip to account menu

himantane

Known as: N-(2-adamantyl)hexamethylenimine hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
An Analysis of the Behavioral and Neurochemical Effects of Himantane on the Dynamics of the Ethanol-Induced Hyperlocomotor Response in DBA/2 Mice
We studied the effect of himantane (N-(2-adamantyl)-hexamethyleneimine hydrochloride) on the ethanol-induced hyperlocomotor… 
2012
2012
Absolute Bioavailability of Himantane in Rabbits
Pharmacokinetic parameters of himantane and its metabolites in the blood plasma of rabbits were compared after single… 
2012
2012
Excretion of Himantane and Its Metabolites with the Urine and Feces in Rats
The levels of himantane and its metabolites in daily urine and feces of rats were measured after intraperitoneal and oral dose of… 
2008
2008
[The possibilities of using himantane in the treatment of Parkinson's disease].
The domestic drug himantane has been used as a monotherapy in dosage 25 mg daily during 12 weeks in patients with Parkinson's… 
2008
2008
Effect of antiparkinsonian drug himantane on the content of dopamine transporter DAT protein in rat striatum and cultured heochromocytoma PC-12 cells
We studied the effects of antiparkinsonian drug himantane (acute and subchronic administration) on the content of dopamine… 
2004
2004
[Estimation of the protective effect of the novel potential antiparkinsonian agent himantane against MPTP neurotoxicity].
N-(Adamant-2-yl)hexamethyleneimine hydrochloride (hemantane) is a new potential antiparkinsonian drug with a complex mechanism of… 
2004
2004
Estimation of the protective effect of the novel potential antiparkinsonian agent himantane against MPTP neurotoxicity
N-(Adamant-2-yl)hexamethyleneimine hydrochloride (hemantane) is a new potential antiparkinsonian drug with a complex mechanism of… 
2003
2003
[Evaluation of the prolonged immunotropic effect of the potential antiparkinson agent himantane].
A prolonged immunotropic effect of himantane, a new potential antiparkinsonian drug with a multicomponent (including… 
2003
2003
[Comparative study of the distribution of 3[H]-himantane in the brain structures and the thymus of rats].
Dynamics of distribution of 3[H]-labeled himantane (N-(adamant-2-yl) hexamethyleneimine hydrochloride), a new drug possessing… 
2001
2001
[Immunotropic activity of a potential antiparkinson agent himantane].
N-(Adamant-2-yl) hexamethyleneimine hydrochloride (A-7, himantane), a new potential antiparkinsonian drug belonging to the class… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)